Thyroid receptor agonists for the treatment of androgenetic alopecia.

Bioorg Med Chem Lett. 2009 Oct 29.
Thyroid receptor agonists for the treatment of androgenetic alopecia.

Li JJ, Mitchell LH, Dow RL.

Department of Chemistry, Michigan Laboratories, Pfizer Global Research & Development, 2800 Plymouth Road, Ann Arbor, MI 48105, United States.

A thyroid hormone receptor beta subtype-selective thyromimetic 5 was found to be efficacious in both mouse and monkey hair growth models after topical applications. It penetrates the skin according to the test in human cadaver skin mounted onto Franz diffusion chambers. The serum drug level of 5 is below the limit of quantification during tests in the bald stump-tailed macaques (Macaca arctoides). It is tested negative in the 3T3 neutral red uptake (NRU) phototoxicity test, indicating a low risk for causing photo-irritation. It is also rapidly metabolized according to the PK data, thus the systemic exposure is limited.

This sounds really interesting, think it could go anywhere CS?

Icanbeatthis - Yes, it seems promising. I've been looking at agonists and they appear safe without some of the potential negative effects of T3 supplementation.

t3 supplement can increase SHBG